Skip to main content
Top
Published in: BMC Infectious Diseases 1/2016

Open Access 01-12-2016 | Research article

Defining cognitive impairment in people-living-with-HIV: the POPPY study

Authors: Davide De Francesco, Jonathan Underwood, Frank A. Post, Jaime H. Vera, Ian Williams, Marta Boffito, Memory Sachikonye, Jane Anderson, Patrick W. G. Mallon, Alan Winston, Caroline A. Sabin, on behalf of the POPPY study group

Published in: BMC Infectious Diseases | Issue 1/2016

Login to get access

Abstract

Background

The reported prevalence of cognitive impairment (CI) varies widely in cohorts of people living with HIV (PLWH); this may partly be due to the use of different diagnostic criteria. Agreement between diagnostic criteria of CI, the optimal definition to use, and associations with patient-reported cognitive symptoms have not been fully investigated.

Methods

Two hundred ninety PLWH aged >50 years and 97 matched negative controls completed a detailed assessment of cognitive function and three questions regarding cognitive symptoms. Age- and education-adjusted test scores (T-scores) determined if subjects met the following definitions of CI: Frascati, global deficit score (GDS) and the multivariate normative comparison (MNC) method.

Results

PLWH were more likely than controls to meet each definition of CI (ORs were 2.17, 3.12 and 3.64 for Frascati, GDS and MNC, respectively). Agreement of MNC with Frascati and GDS was moderate (Cohen’s k = 0.42 and 0.48, respectively), whereas that between Frascati and GDS was good (k = 0.74). A significant association was found between all the three criteria and reporting of memory loss but not with attention and reasoning problems. The 41 (14 %) PLWH meeting all the three criteria had the lowest median global T-score (36.9) and highest rate of symptom reporting (42 %).

Conclusions

Different CI criteria show fair diagnostic agreement, likely reflecting their ability to exclude CI in the same group of individuals. Given the lower overall cognitive performance and higher rates of symptom reporting in those meeting all three criteria of CI, further work assessing this as a definition of CI in PLWH is justified.
Appendix
Available only for authorised users
Literature
1.
go back to reference Robertson KR, Smurzynski M, Parsons TD, Wu K, Bosch RJ, Wu J, et al. The prevalence and incidence of neurocognitive impairment in the HAART era. AIDS. 2007;21(14):1915–21.CrossRefPubMed Robertson KR, Smurzynski M, Parsons TD, Wu K, Bosch RJ, Wu J, et al. The prevalence and incidence of neurocognitive impairment in the HAART era. AIDS. 2007;21(14):1915–21.CrossRefPubMed
2.
go back to reference Heaton RK, Franklin DR, Ellis RJ, McCutchan JA, Letendre SL, LeBlanc S, et al. HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J Neurovirol. 2011;17(1):3–16. doi:10.1007/s13365-010-0006-1.CrossRefPubMed Heaton RK, Franklin DR, Ellis RJ, McCutchan JA, Letendre SL, LeBlanc S, et al. HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J Neurovirol. 2011;17(1):3–16. doi:10.​1007/​s13365-010-0006-1.CrossRefPubMed
3.
go back to reference Winston A, Arenas-Pinto A, Stöhr W, Fisher M, Orkin CM, Aderogba K, et al. Neurocognitive function in HIV infected patients on antiretroviral therapy. 2013. Winston A, Arenas-Pinto A, Stöhr W, Fisher M, Orkin CM, Aderogba K, et al. Neurocognitive function in HIV infected patients on antiretroviral therapy. 2013.
4.
go back to reference Simioni S, Cavassini M, Annoni J-M, Abraham AR, Bourquin I, Schiffer V, et al. Cognitive dysfunction in HIV patients despite long-standing suppression of viremia. AIDS. 2010;24(9):1243–50.PubMed Simioni S, Cavassini M, Annoni J-M, Abraham AR, Bourquin I, Schiffer V, et al. Cognitive dysfunction in HIV patients despite long-standing suppression of viremia. AIDS. 2010;24(9):1243–50.PubMed
5.
go back to reference EACS. Guidelines version 8.0 October 2015. 2015. EACS. Guidelines version 8.0 October 2015. 2015.
6.
go back to reference Reid LM, MacLullich AM. Subjective memory complaints and cognitive impairment in older people. Dement Geriatr Cogn Disord. 2006;22(5-6):471–85.CrossRefPubMed Reid LM, MacLullich AM. Subjective memory complaints and cognitive impairment in older people. Dement Geriatr Cogn Disord. 2006;22(5-6):471–85.CrossRefPubMed
7.
go back to reference Antinori A, Arendt G, Becker J, Brew B, Byrd D, Cherner M, et al. Updated research nosology for HIV-associated neurocognitive disorders. Neurology. 2007;69(18):1789–99.CrossRefPubMedPubMedCentral Antinori A, Arendt G, Becker J, Brew B, Byrd D, Cherner M, et al. Updated research nosology for HIV-associated neurocognitive disorders. Neurology. 2007;69(18):1789–99.CrossRefPubMedPubMedCentral
8.
go back to reference Carey CL, Woods SP, Gonzalez R, Conover E, Marcotte TD, Grant I, et al. Predictive validity of global deficit scores in detecting neuropsychological impairment in HIV infection. J Clin Exp Neuropsychol. 2004;26(3):307–19.CrossRefPubMed Carey CL, Woods SP, Gonzalez R, Conover E, Marcotte TD, Grant I, et al. Predictive validity of global deficit scores in detecting neuropsychological impairment in HIV infection. J Clin Exp Neuropsychol. 2004;26(3):307–19.CrossRefPubMed
10.
go back to reference Su T, Schouten J, Geurtsen GJ, Wit FW, Stolte IG, Prins M, et al. Multivariate normative comparison, a novel method for more reliably detecting cognitive impairment in HIV infection. AIDS. 2015;29(5):547–57. doi:10.1097/qad.0000000000000573.PubMed Su T, Schouten J, Geurtsen GJ, Wit FW, Stolte IG, Prins M, et al. Multivariate normative comparison, a novel method for more reliably detecting cognitive impairment in HIV infection. AIDS. 2015;29(5):547–57. doi:10.​1097/​qad.​0000000000000573​.PubMed
11.
go back to reference Gisslén M, Price RW, Nilsson S. The definition of HIV-associated neurocognitive disorders: are we overestimating the real prevalence? BMC Infect Dis. 2011;11(1):1.CrossRef Gisslén M, Price RW, Nilsson S. The definition of HIV-associated neurocognitive disorders: are we overestimating the real prevalence? BMC Infect Dis. 2011;11(1):1.CrossRef
12.
go back to reference Knippels HM, Goodkin K, Weiss JJ, Wilkie FL, Antoni MH. The importance of cognitive self-report in early HIV-1 infection: validation of a cognitive functional status subscale. AIDS. 2002;16(2):259–67.CrossRefPubMed Knippels HM, Goodkin K, Weiss JJ, Wilkie FL, Antoni MH. The importance of cognitive self-report in early HIV-1 infection: validation of a cognitive functional status subscale. AIDS. 2002;16(2):259–67.CrossRefPubMed
13.
go back to reference Carter SL, Rourke SB, Murji S, Shore D, Rourke BP. Cognitive complaints, depression, medical symptoms, and their association with neuropsychological functioning in HIV infection: a structural equation model analysis. Neuropsychology. 2003;17(3):410.CrossRefPubMed Carter SL, Rourke SB, Murji S, Shore D, Rourke BP. Cognitive complaints, depression, medical symptoms, and their association with neuropsychological functioning in HIV infection: a structural equation model analysis. Neuropsychology. 2003;17(3):410.CrossRefPubMed
14.
go back to reference Hinkin CH, van Gorp WG, Satz P, Marcotte T, Durvasula RS, Wood S, et al. Actual versus self-reported cognitive dysfunction in HIV-1 infection: memory-metamemory dissociations. J Clin Exp Neuropsychol. 1996;18(3):431–43.CrossRefPubMed Hinkin CH, van Gorp WG, Satz P, Marcotte T, Durvasula RS, Wood S, et al. Actual versus self-reported cognitive dysfunction in HIV-1 infection: memory-metamemory dissociations. J Clin Exp Neuropsychol. 1996;18(3):431–43.CrossRefPubMed
15.
go back to reference Van Gorp WG, Satz P, Hinkin C, Selnes O, Miller EN, McArthur J, et al. Metacognition in HIV-1 seropositive asymptomatic individuals: self-ratings versus objective neuropsychological performance. J Clin Exp Neuropsychol. 1991;13(5):812–9.CrossRefPubMed Van Gorp WG, Satz P, Hinkin C, Selnes O, Miller EN, McArthur J, et al. Metacognition in HIV-1 seropositive asymptomatic individuals: self-ratings versus objective neuropsychological performance. J Clin Exp Neuropsychol. 1991;13(5):812–9.CrossRefPubMed
17.
go back to reference Darby DG, Pietrzak RH, Fredrickson J, Woodward M, Moore L, Fredrickson A, et al. Intraindividual cognitive decline using a brief computerized cognitive screening test. Alzheimers Dement. 2012;8(2):95–104.CrossRefPubMed Darby DG, Pietrzak RH, Fredrickson J, Woodward M, Moore L, Fredrickson A, et al. Intraindividual cognitive decline using a brief computerized cognitive screening test. Alzheimers Dement. 2012;8(2):95–104.CrossRefPubMed
18.
go back to reference Harrison J, Maruff P. Measuring the mind: assessing cognitive change in clinical drug trials. Expert Rev Clin Pharmacol. 2008;1(4):471.CrossRefPubMed Harrison J, Maruff P. Measuring the mind: assessing cognitive change in clinical drug trials. Expert Rev Clin Pharmacol. 2008;1(4):471.CrossRefPubMed
19.
go back to reference Maruff P, Thomas E, Cysique L, Brew B, Collie A, Snyder P, et al. Validity of the CogState brief battery: relationship to standardized tests and sensitivity to cognitive impairment in mild traumatic brain injury, schizophrenia, and AIDS dementia complex. Arch Clin Neuropsychol. 2009;24(2):165–78.CrossRefPubMed Maruff P, Thomas E, Cysique L, Brew B, Collie A, Snyder P, et al. Validity of the CogState brief battery: relationship to standardized tests and sensitivity to cognitive impairment in mild traumatic brain injury, schizophrenia, and AIDS dementia complex. Arch Clin Neuropsychol. 2009;24(2):165–78.CrossRefPubMed
20.
go back to reference Steinberg SI, Sammel MD, Harel BT, Schembri A, Policastro C, Bogner HR, et al. Exercise, sedentary pastimes, and cognitive performance in healthy older adults. Am J Alzheimers Dis Other Demen. 2015; 30(3):290-98. Steinberg SI, Sammel MD, Harel BT, Schembri A, Policastro C, Bogner HR, et al. Exercise, sedentary pastimes, and cognitive performance in healthy older adults. Am J Alzheimers Dis Other Demen. 2015; 30(3):290-98.
21.
go back to reference Cysique LA, Maruff P, Darby D, Brew BJ. The assessment of cognitive function in advanced HIV-1 infection and AIDS dementia complex using a new computerised cognitive test battery. Arch Clin Neuropsychol. 2006;21(2):185–94.CrossRefPubMed Cysique LA, Maruff P, Darby D, Brew BJ. The assessment of cognitive function in advanced HIV-1 infection and AIDS dementia complex using a new computerised cognitive test battery. Arch Clin Neuropsychol. 2006;21(2):185–94.CrossRefPubMed
22.
go back to reference McDonnell J, Haddow L, Daskalopoulou M, Lampe F, Speakman A, Gilson R, et al. Minimal cognitive impairment in UK HIV-positive men who have sex with men: effect of case definitions and comparison with the general population and HIV-negative men. J Acquir Immune Defic Syndr (1999). 2014;67(2):120.CrossRef McDonnell J, Haddow L, Daskalopoulou M, Lampe F, Speakman A, Gilson R, et al. Minimal cognitive impairment in UK HIV-positive men who have sex with men: effect of case definitions and comparison with the general population and HIV-negative men. J Acquir Immune Defic Syndr (1999). 2014;67(2):120.CrossRef
23.
go back to reference Overton ET, Kauwe JS, Paul R, Tashima K, Tate DF, Patel P, et al. Performances on the CogState and standard neuropsychological batteries among HIV patients without dementia. AIDS Behav. 2011;15(8):1902–9.CrossRefPubMedPubMedCentral Overton ET, Kauwe JS, Paul R, Tashima K, Tate DF, Patel P, et al. Performances on the CogState and standard neuropsychological batteries among HIV patients without dementia. AIDS Behav. 2011;15(8):1902–9.CrossRefPubMedPubMedCentral
24.
go back to reference Garvey LJ, Yerrakalva D, Winston A. Correlations between computerized battery testing and a memory questionnaire for identification of neurocognitive impairment in HIV type 1-infected subjects on stable antiretroviral therapy. AIDS Res Hum Retrovir. 2009;25(8):765–9.CrossRefPubMed Garvey LJ, Yerrakalva D, Winston A. Correlations between computerized battery testing and a memory questionnaire for identification of neurocognitive impairment in HIV type 1-infected subjects on stable antiretroviral therapy. AIDS Res Hum Retrovir. 2009;25(8):765–9.CrossRefPubMed
25.
go back to reference Fleiss JL, Cohen J, Everitt B. Large sample standard errors of kappa and weighted kappa. Psychol Bull. 1969;72(5):323.CrossRef Fleiss JL, Cohen J, Everitt B. Large sample standard errors of kappa and weighted kappa. Psychol Bull. 1969;72(5):323.CrossRef
26.
go back to reference Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33(1):159–74. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33(1):159–74.
27.
go back to reference Fleiss JL, Levin B, Paik MC. Statistical methods for rates and proportions. John Wiley & Sons, New York; 2013. Fleiss JL, Levin B, Paik MC. Statistical methods for rates and proportions. John Wiley & Sons, New York; 2013.
28.
go back to reference Nakasujja N, Miyahara S, Evans S, Lee A, Musisi S, Katabira E, et al. Randomized trial of minocycline in the treatment of HIV-associated cognitive impairment. Neurology. 2013;80(2):196–202.CrossRefPubMedPubMedCentral Nakasujja N, Miyahara S, Evans S, Lee A, Musisi S, Katabira E, et al. Randomized trial of minocycline in the treatment of HIV-associated cognitive impairment. Neurology. 2013;80(2):196–202.CrossRefPubMedPubMedCentral
29.
go back to reference Fellows RP, Byrd DA, Morgello S. Major depressive disorder, cognitive symptoms, and neuropsychological performance among ethnically diverse HIV+ men and women. J Int Neuropsychol Soc. 2013;19(02):216–25.CrossRefPubMedPubMedCentral Fellows RP, Byrd DA, Morgello S. Major depressive disorder, cognitive symptoms, and neuropsychological performance among ethnically diverse HIV+ men and women. J Int Neuropsychol Soc. 2013;19(02):216–25.CrossRefPubMedPubMedCentral
30.
go back to reference Heaton RK, Franklin DR, Deutsch R, Letendre S, Ellis RJ, Casaletto K, et al. Neurocognitive change in the era of HIV combination antiretroviral therapy: the longitudinal CHARTER study. Clin Infect Dis. 2015;60(3):473–80.CrossRefPubMed Heaton RK, Franklin DR, Deutsch R, Letendre S, Ellis RJ, Casaletto K, et al. Neurocognitive change in the era of HIV combination antiretroviral therapy: the longitudinal CHARTER study. Clin Infect Dis. 2015;60(3):473–80.CrossRefPubMed
31.
go back to reference Donovan NJ, Amariglio RE, Zoller AS, Rudel RK, Gomez-Isla T, Blacker D, et al. Subjective cognitive concerns and neuropsychiatric predictors of progression to the early clinical stages of Alzheimer disease. Am J Geriatr Psychiatry. 2014;22(12):1642–51.CrossRefPubMedPubMedCentral Donovan NJ, Amariglio RE, Zoller AS, Rudel RK, Gomez-Isla T, Blacker D, et al. Subjective cognitive concerns and neuropsychiatric predictors of progression to the early clinical stages of Alzheimer disease. Am J Geriatr Psychiatry. 2014;22(12):1642–51.CrossRefPubMedPubMedCentral
Metadata
Title
Defining cognitive impairment in people-living-with-HIV: the POPPY study
Authors
Davide De Francesco
Jonathan Underwood
Frank A. Post
Jaime H. Vera
Ian Williams
Marta Boffito
Memory Sachikonye
Jane Anderson
Patrick W. G. Mallon
Alan Winston
Caroline A. Sabin
on behalf of the POPPY study group
Publication date
01-12-2016
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2016
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-016-1970-8

Other articles of this Issue 1/2016

BMC Infectious Diseases 1/2016 Go to the issue